Navigation Links
Nouveau Life Offers Potential Distributors Online Access to Company and Contract
Date:8/9/2012

FORT LAUDERDALE, Fla., Aug. 9, 2012 /PRNewswire/ -- Nouveau Life Pharmaceuticals, Inc. (Pink Sheets: NOUV), a provider of quality all-natural dietary supplements, now offers distribution firms an online channel to express their interest in a partnership.

Nouveau Life's website now includes a page dedicated to product distributors. The page contains a form for mass distribution firms to express their interest in partnering with Nouveau Life. A key component of this form is its delivery route – distributor page form submissions are sent directly to Nouveau Life CEO Melissa Walker.

"Distribution partnerships are a critical component in the success of consumer goods companies. I do not want to take the chance of missing an opportunity because an email wasn't forwarded, so I had the web developer route the distributor form submissions directly to my inbox," stated Walker.

Another highlight of the new distributor webpage is the inclusion of a full Nouveau Life Mass Distributor Contract. Allowing upfront access to the contract provides mass distribution firms the ability to assess a possible partnership without the need for an extensive investment of time and it inhibits less-than-serious inquiries. The downloadable contract is complete with the exception of the discount afforded each distributor as this will be negotiated on a per company basis.

For more information or to view the distributor webpage, visit www.nlpnaturals.com/distributor.

About Nouveau Life Pharmaceuticals
The Company, formerly known as Hybrid Fuels, Inc., was incorporated in the state of Nevada in 1998 as Polo Equities. It has primarily been a development stage company with management focused on developing innovative business opportunities and further advancing technologies.

Forward-Looking Statements - This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that could cause future results to differ materially from the forward-looking statements. You should consider these factors in evaluating the statements herein, and not rely on such statements. The forward-looking statements in this release are made as of the date hereof and Nouveau Life Pharmaceuticals, Inc. undertakes no obligation to update such statements.

CONTACT:
Nouveau Life Pharmaceuticals, Inc. - 954-903-2993


'/>"/>
SOURCE Nouveau Life Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Nouveau Life Pharmaceuticals (NOUV) Releases Krill Oil to Support Healthy Cholesterol Levels and Reduce Inflammation
2. The Facelift Alternative by Nouveau Contour
3. Nouveau Life Pharmaceuticals (NOUV) Launches Affiliate Sales Program
4. Nouveau Life Pharmaceuticals (NOUV) In Talks with International Mass Distribution Firms
5. Nouveau Life Pharmaceuticals (NOUV) to Launch Affiliate Sales Program
6. Nouveau Life Pharmaceuticals (NOUV) to Begin Sales of Azul Instant™
7. Hybrid Fuels, Inc. Announces Name Change to Nouveau Life Pharmaceuticals, Inc.
8. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
9. Global Information Inc Offers Big Discounts on Market Forecasts for Surgical Sealants, Wound Closure Products, Spine Surgery Technology, and More
10. New GPS for the Body Offers Treatment Option With Minimal Side Effects For Prostate Cancer Patients
11. Robai Offers Cyton Gamma Humanoid Robot Arm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , December 5, 2016 PharmaBoardroom today releases ... . ... This report offers companies, investors, policymakers, and stakeholders crucial insight ... of Europe , home to some of the world,s ... pharmaceutical companies in Novartis and Roche, and with a number one ranking ...
(Date:12/5/2016)... VIENNA and TAIPEI, Taiwan , ... 12 months of treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea ... demonstrated a significantly better safety and tolerability profile of ropeginterferon ... data from PROUD-PV and the ongoing long-term follow-up trial CONTINUATION-PV ... PharmaEssentia intends to present this data to the ...
(Date:12/4/2016)... ORLEANS , Dec. 2, 2016  Former Attorney General ... Jr., Esq. , a partner at the law firm of ... commenced an investigation into Lannett Company, Inc. (NYSE: ... Bloomberg published an article titled "U.S. Charges in Generic-Drug ... "antitrust investigation by the Justice Department, begun about two years ...
Breaking Medicine Technology:
(Date:12/5/2016)... ... December 05, 2016 , ... The new knee compression sleeves ... to buy neoprene knee sleeves for lifting and any sport that requires ... on two main aspects to provide a higher quality knee sleeve performance. Firstly it ...
(Date:12/5/2016)... , ... December 05, 2016 , ... ... today that they have teamed up with The American College of Surgeons (ACS) ... ACS’s Committee on Trauma, the “Bleeding Control Basic” course is a pilot program ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... and many more tools allowing FCPX editors to create professional looking video in ... , Perfect Harmony contains a beautifully designed 3D environment for placing in ...
(Date:12/4/2016)... ... December 04, 2016 , ... "Pro3rd Displace ... animation styles with unique displacement design elements," said Christina Austin - CEO of ... Choose from a variety of design styles that include both left aligned and ...
(Date:12/2/2016)... ... 2016 , ... Halfway through its partnership with First 5 LA, Western University ... than 15,900 children 5 years old and younger and treatment services to more than ... of five years to Western University of Health Sciences, UCLA and USC, beginning March ...
Breaking Medicine News(10 mins):